Information about Skylight Therapeutics
My details
*
*
*

Skylight Therapeutics (SRL)

BE

1015.430.741

Company information

Status
Active

Enterprise number

BE1015.430.741

VAT liability
Yes
Established
22-10-2024
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Skylight Therapeutics

2025
Income statement
Profit/Loss € -57,733
Gross margin € -54,689
Balance sheet
Balance sheet total € 21,284
Equity € -54,733
Debts € 76,017

Publications from Skylight Therapeutics

Date Publication
24-10-2024 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Skylight Therapeutics?
The VAT number of Skylight Therapeutics is BE 1015.430.741.
Wat is the PEPPOL ID of Skylight Therapeutics?
The PEPPOL ID of Skylight Therapeutics is 0208:1015430741. Log in or start a free trial to see the full overview.
When was Skylight Therapeutics founded?
Skylight Therapeutics was founded on 22-10-2024.
What is the address of Skylight Therapeutics?
The current registered office of Skylight Therapeutics is located at Gaston Geenslaan 2, 3001 Leuven.
When was the last time Skylight Therapeutics filed their annual financial statements?
The most recent financial statements of Skylight Therapeutics were filed on 03-09-2026.
How many employees does Skylight Therapeutics have?
There are currently no employees working at Skylight Therapeutics or no workforce information is available.
What is the annual turnover of Skylight Therapeutics?
At the time of its most recent financial statements, Skylight Therapeutics did not publish any turnover figures. Skylight Therapeutics reported a gross margin of -€54,688.83.

Sources